EcoR1 Capital, LLC 13D and 13G filings for Abeona Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 4:15 pm Sale | 2023-12-31 | 13G | Abeona Therapeutics Inc. ABEO | EcoR1 Capital, LLC | 1,086,956 4.200% | -698,707 (-39.13%) | Filing |
| 2022-11-14 4:56 pm Purchase | 2022-11-03 | 13G | Abeona Therapeutics Inc. ABEO | EcoR1 Capital, LLC | 1,785,663 9.990% | 1,785,663 (New Position) | Filing |